<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71540">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02174406</url>
  </required_header>
  <id_info>
    <org_study_id>14-119</org_study_id>
    <nct_id>NCT02174406</nct_id>
  </id_info>
  <brief_title>Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis</brief_title>
  <official_title>Clinical Utility of Whole Breast Screening Ultrasound in Patients Undergoing Digital Breast Tomosynthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether ultrasound or Digital breast tomosynthesis
      (DBT) detects more cancers and to compare the types of cancers detected on ultrasound and
      DBT.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>estimate the cancer detection rates</measure>
    <time_frame>2 years</time_frame>
    <description>The detection rate of each imaging test is defined as the proportion of patients who are positive on that imaging test who truly have the disease compared to the total number of women screened. A positive imaging test is defined as a test with a recommendation for biopsy (BI-RADS 4 or 5).</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Breast Screening</condition>
  <arm_group>
    <arm_group_label>women scheduled for breast screening</arm_group_label>
    <description>Each patient will have the following:
Screening whole breast ultrasound
DBT (Full field digital mammography + tomosynthesis views in the CC and MLO projections). The only change in patient management will be the addition of digital breast tomosynthesis views in patients scheduled for FFDM alone. DBT is currently clinically approved and being offered on a voluntary basis to patients scheduled for FFDM.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>breast ultrasound</intervention_name>
    <arm_group_label>women scheduled for breast screening</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>DBT (Full field digital mammography + tomosynthesis)</intervention_name>
    <arm_group_label>women scheduled for breast screening</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All women scheduled for a WBUS and a FFDM on the same day or within the following 30 days
        of each other will be identified by the investigators/research staff at MSKCC clinic.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any women scheduled for screening WBUS and a screening FFDM on the same day or within
             the following 30 days of each other.

        Exclusion Criteria:

          -  Age &lt; 30 years old

          -  Male patients

          -  Patients with any clinical symptoms (palpable mass, nipple discharge, etc)

          -  Patients with known cancer

          -  Patients with any breast surgery or biopsy within 90 days prior to the study

          -  Patients with breast implants

          -  Patients pregnant or lactating
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janice Sung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Janice Sung, MD</last_name>
    <phone>646-888-5423</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher Comstock, MD</last_name>
    <phone>646-888-4500</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice Sung, MD</last_name>
      <phone>646-888-5423</phone>
    </contact>
    <contact_backup>
      <last_name>Christopher Comstock, MD</last_name>
      <phone>646-888-4500</phone>
    </contact_backup>
    <investigator>
      <last_name>Janice Sung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 14, 2016</lastchanged_date>
  <firstreceived_date>June 23, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Ultrasound</keyword>
  <keyword>Digital Breast Tomosynthesis</keyword>
  <keyword>14-119</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
